Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 11

1.

Challenges of Treating Acute Heart Failure in Patients with Chronic Obstructive Pulmonary Disease.

Čelutkienė J, Balčiūnas M, Kablučko D, Vaitkevičiūtė L, Blaščiuk J, Danila E.

Card Fail Rev. 2017 Apr;3(1):56-61. doi: 10.15420/cfr.2016:23:2.

2.

Heart failure, chronic obstructive pulmonary disease, and asthma: numbers, facts, and challenges.

Lainscak M, Anker SD.

ESC Heart Fail. 2015 Sep;2(3):103-107. Epub 2015 Jul 31.

3.

Hyperlipidemia in COPD is associated with decreased incidence of pneumonia and mortality: a nationwide health insurance data-based retrospective cohort study.

Chan MC, Lin CH, Kou YR.

Int J Chron Obstruct Pulmon Dis. 2016 May 18;11:1053-9. doi: 10.2147/COPD.S102708. eCollection 2016.

4.

Ivabradine prevents heart rate acceleration in patients with chronic obstructive pulmonary disease and coronary heart disease after salbutamol inhalation.

Zulkarneev R, Zagidullin N, Abdrahmanova G, Hoppe UC, Zagidullin S.

Pharmaceuticals (Basel). 2012 Apr 16;5(4):398-404. doi: 10.3390/ph5040398.

5.

Inhaled anticholinergic use and all-cause mortality among elderly Medicare beneficiaries with chronic obstructive pulmonary disease.

Ajmera M, Shen C, Pan X, Findley PA, Rust G, Sambamoorthi U.

Int J Chron Obstruct Pulmon Dis. 2013;8:287-94. doi: 10.2147/COPD.S45166. Epub 2013 Jun 10.

6.

Efficacy and safety of eco-friendly inhalers: focus on combination ipratropium bromide and albuterol in chronic obstructive pulmonary disease.

Panos RJ.

Int J Chron Obstruct Pulmon Dis. 2013;8:221-30. doi: 10.2147/COPD.S31246. Epub 2013 Apr 30. Review.

7.

A new user cohort study comparing the safety of long-acting inhaled bronchodilators in COPD.

Jara M, Wentworth C 3rd, Lanes S.

BMJ Open. 2012 May 22;2(3). pii: e000841. doi: 10.1136/bmjopen-2012-000841. Print 2012.

8.
9.

Inhaled tiotropium bromide and risk of stroke.

Grosso A, Douglas I, Hingorani AD, MacAllister R, Hubbard R, Smeeth L.

Br J Clin Pharmacol. 2009 Nov;68(5):731-6. doi: 10.1111/j.1365-2125.2009.03517.x.

10.

Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity.

Finkelstein J, Cha E, Scharf SM.

Int J Chron Obstruct Pulmon Dis. 2009;4:337-49. Epub 2009 Sep 24.

11.

A systematic review of the cardiovascular risk of inhaled anticholinergics in patients with COPD.

Hilleman DE, Malesker MA, Morrow LE, Schuller D.

Int J Chron Obstruct Pulmon Dis. 2009;4:253-63. Epub 2009 Jul 20. Review.

Supplemental Content

Support Center